UNSPSC 85642758: Inspection of head and neck subcutaneous tissue and fascia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to inspection of head and neck subcutaneous tissue and fascia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JJS3ZZ

UNSPSC 85642758 Inspection of head and neck subcutaneous tissue and fascia, percutaneous approach is a Commodity code that shows minimal alignment between its nominal medical taxonomy and the state and local opportunities recently posted under it. The recent solicitations tagged with this code do not reflect head-and-neck tissue inspection work but instead cover a range of occupational health services, medical benefits administration, and health professional staffing — none of which correspond to the specific clinical procedure the code names.

The Washington State Department of Transportation's Washington State Ferries division posted an RFP for occupational medical surveillance services due October 9, 2026, requiring baseline and periodic examinations for shipyard workers, engine crew, and asbestos-exposed personnel across 14 Washington ferry locations; the City of Phoenix Retirement Office posted an RFP for independent medical evaluation and disability benefit determination services due October 16, 2026; Harris County Juvenile Probation Department issued an RFI for emergency and specialty medical services for detained youth due September 25, 2026; the City of Long Beach posted an RFP for surgical carve-out benefits under a Center of Excellence model due October 7, 2026; the County of Santa Clara Health System posted a non-exclusive multiple-award qualification pool for temporary health professional staffing across ancillary clinical categories due October 7, 2026; and Collier County posted an RFP for pharmacy benefit management services covering approximately $8.7 million in annual pharmacy spend. The code shows little relevant recent activity under its stated scope and appears misclassified across these opportunities.